Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Liver Cancer|December 24, 2021
Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular CarcinomaTomoko Aoki, Naoshi Nishida, Kazuomi Ueshima, et al.
BMC Gastroenterology|June 23, 2026
Curative treatment is feasible for recurrent hepatocellular carcinoma regardless of recurrence pattern after hepatitis C virus eradication with interferon-free direct-acting antiviral therapySatoru Hagiwara, Takuya Matsubara, Naoya Omaru, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 31, 2022
Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infectionSatoru Hagiwara, Naoshi Nishida, Hiroshi Ida, et al.
Digestive Diseases (Basel, Switzerland)|November 8, 2014
Genome-wide profiling of DNA methylation and tumor progression in human hepatocellular carcinomaNaoshi Nishida, Takafumi Nishimura, Takuya Nakai, et al.
Internal Medicine (Tokyo, Japan)|July 16, 2025
Complete Remission of Acute-onset Autoimmune Hepatitis Following Transcatheter Splenic Arterial Embolization and Splenectomy for Spontaneous Splenic RuptureIkue Sekai, Masahiro Takita, Shigenobu Yasuhara, et al.
Oncology|December 16, 2016
Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver DiseaseSatoru Hagiwara, Naoshi Nishida, Tomohiro Watanabe, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2016
Outcome of Asunaprevir/Daclatasvir Combination Therapy for Chronic Liver Disease Type CSatoru Hagiwara, Naoshi Nishida, Tomohiro Watanabe, et al.
Oncology|November 20, 2015
Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center ExperienceYasunori Minami, Tomohiro Minami, Hirokazu Chishina, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2017
Hepatocarcinogenesis Is Associated with Serum Albumin Levels after Sustained Virological Responses with Interferon-Based Therapy in Patients with Hepatitis CYasuko Umehara, Satoru Hagiwara, Naoshi Nishida, et al.
Liver Cancer|August 20, 2021
Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 AntibodyMasahiro Morita, Naoshi Nishida, Kazuko Sakai, et al.
Pageof 6